• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

3v.org

Venture Capital Matters

  • Pitch a Startup
    • Make a Contribution
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

LumiThera Closes 2nd Tranche of Series C Financing

January 13, 2020 By admin Leave a Comment

LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has closed the 2nd tranche of its Series C round of financing. The proceeds of the financing are being used to support further clinical testing and commercialization of its Valeda® Light Delivery System for the treatment of dry Age-related Macular Degeneration (AMD).

“We are pleased with the investor interest in the company and have raised over $10M in the current C round,” stated Clark Tedford, Ph.D., President and CEO. “The capital raised will allow us to execute on our European and US multi-center clinical trials.”

WaterStar Capital, an Atlanta, Georgia based venture capital fund, led the round. “WaterStar is very excited at the progress of LumiThera in 2019 and looks forward to helping in the global commercialization of the PBM technology for ocular disease,” stated Yigang Yang, WaterStar’s co-founder and managing partner.

LumiThera and Optos announced a distribution agreement in 4Q of 2018 to sell the Valeda in 12 countries in Europe. Optos, a division of Nikon Corporation, has the only ultra-widefield retinal imaging company for eye care. Nikon participated in the current C round as a LumiThera investor.

The company is currently conducting prospective, randomized, double masked, clinical trials in dry AMD subjects. The company’s LIGHTSITE II study is a European multi-center post-marketing study, and its LIGHTSITE III study is an FDA-approved IDE, multi-center study in the U.S. utilizing the LumiThera Valeda system.

Visit the Company’s website at www.lumithera.com.

About LumiThera Inc.
LumiThera is a commercial-stage medical device company focused on treating people affected by ocular disorders and diseases including dry AMD, a leading cause of blindness in adults over 65. The company is a leader in the use of PBM for treatment of acute and chronic ocular diseases and disorders. The company is developing the office based Valeda Light Delivery System to be used by eye care specialists for medical treatment.

The Valeda Light Delivery System has been granted authorization to use the CE Mark by an EU Notified Body as required for commercial use in the European Economic Area only. Valeda is not approved for use by the Food & Drug Administration (FDA) in the USA.

SOURCE LumiThera Inc.

Home

Filed Under: PR Tagged With: LumiThera, PBM, PBM technology, clinical trial, ocular disease, photobiomodulation

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

Event Calendar
Job openings hit a record high March
The construction industry is responsible for 11% of the world’s man-made carbon emissions
Differential Privacy Tools
Global Derivatives Regulatory Roundup
VCmatters.com: India overtook the UK to rank third among nations having the most number of unicorns
There will be around 12 million tons of batteries retiring from EV between now and 2030

Market Research Media

GenZnomads.com: Gen Z Nomads Want to Work from Home
RealityCheckout.com (Reality Checkout): How do the past tech predictions fare?
BRIC Investment Funds Have Taken a Beating This Year
PublicDonmain.ai: You can’t copyright AI-created art
ResilientSupplies.com: Resilient Supplies, the Name of the Game for the Global Supply Chain
ExecutiveTravelMetaverse.com (Executive Travel Metaverse): Corporate travel market is about to become more competitive
SetupMarket.com: How to set up a direct-to-consumer (DTC) channel

Secondary Sidebar

Technologies

Omdia Releases White Paper on the Enduring Value of IP + Optical
Breakthrough Technologies 2021
Green Ammonia and Hydrogen Now Cheaper than Fossil Fuels
Technology Segment is the Largest Creator of Value
Cloudflare ‘s 1.1.1.1 handling more than 1 trillion requests per day

Tech Events

Microsoft Research Summit, October 19-21, 2021
TechCrunch held The Disrupt 2021 online on September 21-23
DesignCon, the premier event in high-speed communications and system design, August 16-18 2021, San Jose McEnery Convention Center
ACM SIGGRAPH Reveals Final SIGGRAPH 2020 Numbers, 2021 Planning
Extreme Networks “Connect” User Conference Returns to Nashville June 6-9, 2022

Footer

Recent Posts

  • How to achieving gender balance in management teams
  • When you feel like you’re spiraling
  • After Successful Tax Season, Embedded Tax Platform April Raises $30M Series A from Fintech Veterans
  • Vita Mojo Raises US$30 Million to Help Restaurant and Hospitality Chains in Europe Tackle the Digital Future
  • Nautical Commerce Raises $30M to Scale Multi-Vendor Marketplace Technology
  • Token Announces $13 Million Series B Funding Round and Appointment of New CEO to Disrupt the Authentication Market
  • Konnecto Raises $21M to establish a new category in marketing technology
  • Sharebite, the Leading Food Benefits Platform, Announces Closing of $39 Million Series B Round
  • Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
  • Biotech companies have received significant VC funding in the past three years

Dossier

AeroVironment Acquires Telerob, a Leader in Ground Robotic Solutions, to Expand Multi-Domain Unmanned Systems Offering and Global Presence
Hopin Acquires Boomset, Becoming an All-in-One Event Management Platform for Virtual, Hybrid and In-person Experiences
Accenture Acquires LEXTA to Expand Capabilities in IT Benchmarking, Sourcing and Advisory
Square, Inc. Announces Plans to Acquire Afterpay, Strengthening and Enabling Further Integration Between its Seller and Cash App Ecosystems
Deloitte Acquires Zero Trust Network Access Provider TransientX

Press Media Release

Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
Apple Fitness+ Welcomes People at Every Fitness Level to Train Their Bodies and Minds with Meditation and New Workouts Available September 27
Space Control Veteran Rob Baker Joins System High as Vice President, Strategic Space Protection
ATTOM UNVEILS INNOVATIVE CLOUD-BASED PLATFORM OFFERING INSTANT AND DIRECT ACCESS TO ITS DATA
Media Advisory: Demonstrations of New 5G Research Testbed Thursday at RELLIS

App Coding

Datadog Named a Leader in the 2022 Gartner® Magic Quadrant™ for Application Performance Monitoring and Observability
How to build a search engine
Registered yet for Cloudflare Connect London 2022?
Code Intelligence raises $12M Series A
NLP techniques are bridging the gap between text documents

API Coding

Five Steps to a Secure Cloud Architecture
Types of API Testing
Profound Logic Builds IBM i Salesforce API Integration Example without Writing a Single Line of Code
DarkOwl Announces Release of Ransomware API
One AI to Take on Global Language AI Challenge with NLP-as-a-service Platform for Developers

Copyright © 2022 3v.org

Technologies, Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT